VTv Therapeutics Inc. said it reduced its workforce by about 65% as it prioritizes development of diabetes drug TTP399.
from MarketWatch.com - Top Stories https://ift.tt/3rG6qZC
via IFTTT
from MarketWatch.com - Top Stories https://ift.tt/3rG6qZC
via IFTTT
Kommentare
Kommentar veröffentlichen